HMG-CoA降解酶抑制剂 (他类药物) 可能保持肝功能并减少在补偿性晚期慢性肝病中门户系统的关闭:SHUNT-V研究的结果
Robert S Rahimi1, Edward Mena2, Kathryn J Lucas3
1Baylor Scott and White Health, Dallas, TX, US.
Clinical and translational gastroenterology
|January 26, 2026
概括
某些药物,包括他类药物和甲胺,可能有助于保持肝功能,并减少补偿性肝硬化患者的分工. 这一发现对于控制肝病进展至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 补偿性肝硬化进展与肝功能障碍和门-系统性分流有关.
- 影响这些变化的因素,包括药物使用,尚不清楚.
研究的目的:
- 调查肝脏疾病病因,糖尿病和药物治疗与肝功能障碍和门系统变流的关联.
主要方法:
- 在SHUNT-V研究中,255名患有补偿性肝硬化的患者接受了巧拉酸挑战测试.
- 测量血清胆酸盐度以评估整体肝功能 (疾病严重性指数 - DSI) 和门系统性分流 (SHUNT%).
主要成果:
- 48%的参与者患有MASLD/MASH,51%患有II型糖尿病 (DM).
- 在无变量分析中,甲胺和他类药物与较低的DSI和SHUNT%有关.
- 降脂药和抗糖尿病药的联合使用可将DSI降低19%.
结论:
- 同时使用他类药物和/或甲胺独立地与肝功能保存 (DSI) 相关.
- 这些药物类别也与 portal-systemic shunting (SHUNT%) 的减少有关.
相关概念视频
Shunt Admittances
496
Shunt admittances play a crucial role in the analysis of transmission lines, particularly for three-phase systems with neutral conductors. When a uniformly charged conductor is positioned above the Earth, it induces an equal but opposite charge on its surface. This interaction creates electric field lines between the conductor and the Earth.
To model this effect, the method of images is employed. This method involves replacing the Earth with an image conductor that mirrors the original...
To model this effect, the method of images is employed. This method involves replacing the Earth with an image conductor that mirrors the original...
496
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
192
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
192
Hepatic Portal System
5.7K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.7K
Overview of Advanced Functional Groups
29.7K
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
29.7K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
269
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
269
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
224
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
224


